Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis
Open Access
- 2 November 2016
- journal article
- research article
- Published by Wiley in Clinical and Translational Science
- Vol. 10 (1), 28-34
- https://doi.org/10.1111/cts.12428
Abstract
There is a significant unmet need for safe and effective anti-inflammatory treatment for cystic fibrosis. The aim of this study was to evaluate the safety of acebilustat, a leukotriene A4 hydrolase inhibitor, and its effect on inflammation biomarkers in patients with cystic fibrosis. Seventeen patients with mild to moderate cystic fibrosis were enrolled and randomized into groups receiving placebo or doses of 50 mg or 100 mg acebilustat administered orally, once daily for 15 days. Sputum neutrophil counts were reduced by 65% over baseline values in patients treated with 100 mg acebilustat. A modestly significant 58% reduction vs. placebo in sputum elastase was observed with acebilustat treatment. Favorable trends were observed for reduction of serum C-reactive protein and sputum neutrophil DNA in acebilustat-treated patients. No changes in pulmonary function were observed. Acebilustat was safe and well tolerated. The results of this study support further clinical development of acebilustat for treatment of cystic fibrosis.Keywords
This publication has 47 references indexed in Scilit:
- Human Neutrophil Elastase Degrades SPLUNC1 and Impairs Airway Epithelial Defense against BacteriaPLOS ONE, 2013
- Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trialJournal of Cystic Fibrosis, 2013
- Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and FcγR signalingProceedings of the National Academy of Sciences of the United States of America, 2012
- The relationship of systemic inflammation to prior hospitalization in adult patients with cystic fibrosisBMC Pulmonary Medicine, 2012
- Lipid-cytokine-chemokine cascades orchestrate leukocyte recruitment in inflammationJournal of Leukocyte Biology, 2011
- Role of LTB4in the pathogenesis of elastase-induced murine pulmonary emphysemaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- A Critical Role for LTA 4 H in Limiting Chronic Pulmonary Neutrophilic InflammationScience, 2010
- LeukotrienesThe New England Journal of Medicine, 2007
- Role of neutrophil elastase in LTB4‐induced neutrophil transmigration in vivo assessed with a specific inhibitor and neutrophil elastase deficient miceBritish Journal of Pharmacology, 2007
- Association between Pulmonary Function and Sputum Biomarkers in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2007